Cardiff Oncology, Inc. (CRDF)
2.87
-0.21
(-6.82%)
USD |
NASDAQ |
Jan 12, 16:00
2.86
-0.01
(-0.35%)
After-Hours: 20:00
Cardiff Oncology Research and Development Expense (Quarterly): 8.197M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agenus, Inc. | 23.60M |
| AIM ImmunoTech, Inc. | 0.525M |
| Perspective Therapeutics, Inc. | 19.56M |
| Protalix Biotherapeutics, Inc. | 4.467M |
| Armata Pharmaceuticals, Inc. | 5.824M |